In a Significant Sign of Momentum for Sen. Warnock's $35 Insulin Cap Bill, Insulin-Maker Sanofi Caps Insulin at $35 for Uninsured Patients
July 01, 2022
July 01, 2022
WASHINGTON, July 1 -- Sen. Raphael G. Warnock, D-Georgia, issued the following statement:
* * *
This week, U.S. Senator Reverend Raphael Warnock (D-GA) released the following statement in response to insulin manufacturer Sanofi announcing they will cap the cost of insulin to $35 a month for all uninsured U.S. patients.
This announcement follows the Senator's legislation and months long campaign to pass his Affordable Insulin Now Act, capping the cost o . . .
* * *
This week, U.S. Senator Reverend Raphael Warnock (D-GA) released the following statement in response to insulin manufacturer Sanofi announcing they will cap the cost of insulin to $35 a month for all uninsured U.S. patients.
This announcement follows the Senator's legislation and months long campaign to pass his Affordable Insulin Now Act, capping the cost o . . .